European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- High Quality 〈EXTENDED | 2025〉

The European Pharmacopoeia is a living document, constantly updated to reflect scientific advances and regulatory needs. Ph. Eur. Supplement 9.3, which came into force on , brought significant revisions to monograph 0478. Key updates included:

While not always mandatory for final release, tests for Friability (2.9.7) and Resistance to Crushing (2.9.8) are used during production to ensure tablets don't crumble during handling. Recent Regulatory Updates

The is the foundational quality standard for tablets intended for oral administration in Europe. Published by the European Directorate for the Quality of Medicines & HealthCare (EDQM) , it establishes legally binding requirements for the definition, production, and testing of diverse tablet forms to ensure patient safety and therapeutic efficacy. 1. Scope and Definition European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

Compliance with Ph. Eur. 0478 is not optional for companies marketing products in member states of the Council of Europe. It provides the "common language" for quality, ensuring that a tablet bought in France meets the exact same structural and performance standards as one bought in Germany or Norway.

Disintegration is a critical benchmark for how a tablet breaks down in the body. Standard limits include: The European Pharmacopoeia is a living document, constantly

The European Pharmacopoeia (Ph. Eur.) is a publication that contains a set of monographs and general chapters that describe the official standards for medicines in Europe. The Ph. Eur. is published by the European Directorate for the Quality of Medicines & Healthcare (EDQM), which is a part of the Council of Europe. The Ph. Eur. is recognized as a standard for the quality of medicines in many countries, including all European Union member states.

Intended to be dissolved or dispersed in water before intake. Supplement 9

: Modified-release formulations engineered to resist gastric fluid and release the API within the intestinal tract.